BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24930451)

  • 1. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
    Kozielewicz D; Zaleśna A; Dybowska D
    Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients.
    Dogan UB; Golge N; Akin MS
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1312-6. PubMed ID: 23652913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.
    Pavan MH; Pavin EJ; Gonçales FL; Zantut-Wittmann DE; Wittmann DE
    Braz J Infect Dis; 2011; 15(5):449-56. PubMed ID: 22230851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha.
    Liu Y; Zheng Y; Lin X; Cao Z; Lu J; Ma L; Ren S; Zheng S; Hu Z; Xu B; Chen X
    BMC Endocr Disord; 2023 May; 23(1):115. PubMed ID: 37217910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
    Huang YX; Chen XY; Ma LN; Yin JM; Ren S; Guo DD; Zheng YH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):216-20. PubMed ID: 22475143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience.
    Ratnam D; Dev A; Nguyen T; Sundararajan V; Harley H; Cheng W; Lee A; Rusli F; Chen R; Bell S; Pianko S; Sievert W
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1447-53. PubMed ID: 22168789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
    Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
    Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long-term follow-up study.
    Ma Z; Qin Y; Jia Y; Xie Y; Qi X; Guo Y; He J; Zhang Y; Li F; Yu J; Zhu H; Yang F; Zhang Y; Mao R; Zhang J
    J Viral Hepat; 2022 Jun; 29(6):412-419. PubMed ID: 35293082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
    Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.
    Savvas SP; Papakostas N; Giannaris M; Malaktari S; Koskinas J; Archimandritis AJ
    South Med J; 2010 Jun; 103(6):585-8. PubMed ID: 20710148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function in patients with chronic hepatitis C virus infection under interferon therapy.
    Abdel-Kader ME; Azmy MK; Hassan MA; Ahmad YK; El-Dahshan T; Houssein MA
    J Egypt Soc Parasitol; 2012 Dec; 42(3):761-8. PubMed ID: 23469650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B.
    Zhang Y; Zhang WL; Pang XW; Wang LX; Wei X; Huang CX; Bai XF; Han S; Liu LN; Lian JQ
    Virol J; 2017 Mar; 14(1):49. PubMed ID: 28274240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
    Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
    Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged duration of the routine pegylated-interferon alfa-2a therapy produces superior virological response in HBeAg-positive chronic hepatitis B patients: a single-center cohort study].
    Zhu YY; Wu YL; Chen J; Zheng Q; Dong J; Jiang JJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):737-41. PubMed ID: 23207332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and clinical characteristics of thyroid disease induced by chronic hepatitis B treated with polyethylene glycol (peg) interferon-alpha].
    Chen XF; Chen XP; Ma XJ; Chen WL; Huang J; Luo XD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):117-9. PubMed ID: 23002550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.
    Zhang RW; Shao CP; Huo N; Li MR; Xi HL; Yu M; Xu XY
    World J Gastroenterol; 2015 Sep; 21(33):9765-73. PubMed ID: 26361424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.